Immunotherapy against CMV to help organ recipients

Autologous adoptive T-cell therapy has been successfully used to fight recurrent or drug-resistant cytomegalovirus (CMV) infections in recipients of solid organ transplants. The phase 1 clinical trial, led by the QIMR Centre for Immunotherapy and Vaccine Development, treated 13 patients with in vitro-expanded autologous CMV-specific T cells. Patients, from the Princess Alexandra and Prince Charles ...